Head-to-head comparisons of medication uses, side effects, warnings, and more.
Qsymia (phentermine / topiramate ER)
Zepbound (tirzepatide)
Qsymia (phentermine / topiramate ER)
Zepbound (tirzepatide)
Summary of Qsymia vs. Zepbound
Summary for Sympathomimetic / Antiepileptic
Prescription only
Qsymia (phentermine / topiramate extended release) is a combination medication used to help with weight loss. It's approved for people over 12 who are considered obese and for some adults who are considered overweight. This medication is a tablet that you take once a day. You should also eat a balanced diet and exercise regularly for best results. Side effects include a "pins-and-needles" feeling, dry mouth, and constipation. You can only get this medication through the Qsymia REMS (Risk Evaluation and Mitigation Strategies) program because of the risk of birth defects if taken during pregnancy.
Summary for GIP and GLP-1 agonist
Prescription only
Zepbound, a brand name for tirzepatide, is an injectable medication that's used along with diet and exercise to help with weight loss. It's approved for certain adults who meet criteria for weight management therapy. Zepbound (tirzepatide) is also approved to treat moderate-to-severe sleep apnea. This medication belongs to the drug class called GIP and GLP-1 agonists. The typical dosage is 1 injection under the skin once per week. Common side effects include nausea, diarrhea, stomach pain, and injection site reactions.
Indications of Qsymia vs. Zepbound
Indications for
•Weight loss and long-term weight management, together with diet and exercise, for certain people: